Epidemiological Analysis of 9,064 Cases of Non-Hodgkin Lymphoma  

作　　者：Li Liu Zhen Ruan 

机构地区：[1]Quzhou City Qujiang District Life Oasis Public Welfare Service Center,Quzhou 324007,China [2]Beijing Health Alliance Charitable Foundation,Beijing 100024,China

出　　处：《Proceedings of Anticancer Research》2025年第2期77-82,共6页抗癌研究

摘　　要：Objective:This study aimed to investigate the epidemiological characteristics and treatment regimens of non-Hodgkin lymphoma(NHL)in China through a retrospective analysis of 9,064 NHL cases.Methods:Clinical data of 9,064 patients were collected from 555 hospitals in 28 provinces of China.Results:Among 9,064 NHL patients,there were 5,241 males(57.8%)and 3,823 females(42.2%),with a male-to-female ratio of 1.37:1.Patients aged≥45 years accounted for 89.6%,with a mean age of 61.87±13.30 years.The predominant NHL subtypes were diffuse large B-cell lymphoma(DLBCL,45.2%),chronic lymphocytic leukemia/small lymphocytic lymphoma(CLL/SLL,19.8%),marginal zone lymphoma(MZL,13.9%),mantle cell lymphoma(MCL,9.7%),and central nervous system lymphoma(CNSL,4.3%).Combination therapy served as the primary treatment modality across all NHL subtypes.Conclusions:NHL in China demonstrates male predominance and primarily affects middle-aged and elderly populations,with combination chemotherapy remaining the mainstay therapeutic approach.

关 键 词：Non-Hodgkin lymphoma EPIDEMIOLOGY Treatment regimen 

分 类 号：R733.1[医药卫生—肿瘤]